Skip to main content

Article

Aging workforce and the impact on drug spend

An estimated 23% of the workforce will be over age 65 by 2050 – but what does that mean for my drug plan?

October 7, 2024 | 6-minute read

In this article

Evidence is growing that as the Baby Boom generation continues to age, they are also continuing to work full time. In 1987, only 11% of those over age 65 were employed. But today that figure is closer to 20%, or, about 6.6% of the total workforce.1

By 2032, it’s projected that nearly 9% of the workforce will be 65 and up – representing well over half of all labor force growth during that time.2 And the trend is expected to accelerate. By 2050 some estimate that 23% of the workforce will be over age 65.3 This raises a natural question: Will an older workforce drive up employer drug costs?

Here’s a look at some of the issues that are driving older people to keep working, as well as potential links between the aging workforce and employer drug spend.

Boomers continue to drive change

The first Baby Boomers began to turn 65 in 2011. In the years since, the percentage of Americans aged 65 and older has grown by more than one third – to nearly 17% of the population.4

But aside from their percentage of the population, the reason we’re interested in the Boomers here is that so many of them are still working.

A line graph that shows the percentage of people working after age 65.

The percentage of workers aged 65 through 74 is projected to rise by more than 83% by the year 2028. Meanwhile, the number of workers over age 75 will increase by 157%.

Why are people still working?

There are several powerful forces keeping older workers on the job:

They need the money

Old-style pensions have largely disappeared. They’ve been replaced by personal savings or contributory investment plans, like 401(k)s.5 However, in 2023 the median value (half larger, half smaller) of 401(k) balances for those age 65 and older was only $88,488.6 That amount might last about 9 years if you withdrew just $1,000 per month.7

Changes to Social Security

These changes have pushed back the age when workers can claim their full retirement benefits – from 65 to 67. Economists believe this has encouraged people to delay retirement and continue working.8  

The economy is more age friendly

Since 1990, the modern economy has become more age friendly for older workers. Fewer jobs require sheer physical stamina instead of thinking skills, and flexible schedules are more common, for example.9

Running short on skilled, educated workers

On the demand side, hiring managers are waking up to the fact that they are running short of the kind of skilled, educated workers they need to drive growth.10 One of the main reasons is that Gen X – the generation that came after the Boomers – is a much smaller cohort. There simply aren’t enough of them to fill the jobs opened by retiring Baby Boomers.11

The bottom line is that 30 years ago only 12% of workers in the U.S. expected to work past age 65. Today we find that 66% of those age 60 and over expect to either keep working past age 65 or never retire at all.12

What’s the impact on drug spend?

There are a multitude of issues surrounding the rise of the “multigenerational workforce.” Everything from cross-cultural integration to job re-design, and the value of critical thinking skills among older workers has attracted intensive research.13, 14, 15

But we are interested in a simple question: Will older workers increase drug spend?

While there is plenty of data about drug costs among the Medicare population, there’s no readily available data concerning drug spending among full time employees aged 65 and over. Accordingly, for now we can only make some general observations. These center around three issues: prescription medications for chronic conditions, polypharmacy in older adults and how long seniors may actually spend working.

Prescription medications for chronic conditions

By age 60, most Americans are taking at least one prescription medication for chronic conditions like high blood pressure, high cholesterol or diabetes.16

A graph that demonstrates the 5 most common prescriptions for ages 60 to 79.

This graph shows the top five most used prescription drugs for those over age 60.

The good news here is that the most commonly used medications among those aged 60 and up are also some of the least expensive on the market.

For example, lipid-lowering drugs (e.g. statins), have retail prices starting at $9-$13 per month, while popular ACE Inhibitors are often priced from $6-$20 per month.17  

Polypharmacy in older adults

One thing to remember about chronic conditions is that as we age, we tend to accumulate medical conditions.18 In fact, about 30% of those aged 60 and up use five or more prescription drugs regularly.19 This is known as polypharmacy.

Now, there may be sound clinical reasons for taking each medication. But polypharmacy usually refers to when some medications may be unnecessary – or even harmful.20 Adverse events from polypharmacy can lead to poor health outcomes and decreased quality of life.21

Polypharmacy can also drive up costs. Among patients with cardiovascular diseases, the average pharmacy-related expenditure in those with polypharmacy was 164% higher than for those without polypharmacy.22

The Optum Rx Polypharmacy Value Management program can identify medications that are causing harm or are no longer beneficial. It incorporates a member’s values and preferences alongside current clinical standards of practice to bring about the best health care decisions for our members.

How long will people really work?

The numbers seem to indicate that employers will need to hire more – and older – workers in the coming years. But how long will these people actually stay on the job?

Many people begin to feel the effects of age in their 60s. In fact, new research has found that by the time we reach our 60s there are significant metabolic differences associated with heart and kidney function. This could explain why older people are more susceptible to type 2 diabetes, cardiovascular disease and kidney issues.23 These natural changes may matter quite a bit when it comes to employment.

Most people enter their retirement-age years assuming that they will continue to work full time, for a long time. One study found that 66% of 50-year-old workers say they plan to work past 65 or never retire at all (left pie chart).  But in reality, 72% of retirees had to stop working by age 62 – far sooner than they expected.A pie chart that compares the expected retirement age with the actual retirement age

A whopping 72% of workers wind up retiring before or right at age 65 – much earlier than planned.

 

Why do such a large percentage retire before they planned? In short, life happens.

Some people get sick. 45% had to retire for health reasons such as physical limitations, disability or ill health. About one-third say it’s because of changes at their place of work – layoffs, reorganizations, changing job requirements. Some even discover that they can afford to retire after all, whether due to an inheritance or some other windfall.24

Regardless of the reason, the net effect is that people tend to work far less after age 65 than they planned – five years less at the median.

Maybe this isn’t really a problem?

We may be seeing why there isn’t a lot of data about the cost of prescription drugs for older workers. Of course, seniors who are healthy enough to work will inevitably incur drug costs, just like everyone else. But their costs appear relatively low, like for statins or ACE inhibitors.

Once the biological clock begins to chime-in more serious conditions, people appear to simply retire and join Medicare to deal with them. There are obvious exceptions –  older workers who receive a costly specialty biologic drug or gene therapies. But these are rare across the board – only 2% or so of all claims.25

In short, it seems like a case of the dog that didn’t bark. With 10,000 Boomers turning 65 every day since 2011, we’d expect any dramatic surge in drug spend to have shown up by now. The fact that no one is talking about it says a lot.

Related healthcare insights

Article

How to manage medication overload

Hear from a leader's perspective on how to manage polypharmacy.

Article

Pharmacy benefit managers add value lower costs

PBMs don’t cause high drug costs — they’re part of the solution. Our drug prices beat the “low cost” vendors.

Article

3 ways to beat vaccine fatigue

Learn about researched vaccine messaging themes and important steps you can take to promote critical vaccinations for members.

Sources

1. Pew Research Center. The growth of the older workforce. Published December 14, 2023. Accessed July 29, 2024.
2. ibid.
3. Forbes. What Will Happen To The Labor Market When Boomers Retire—Or Yet, Don’t Leave The Workforce? Published February 26, 2024. Accessed September 4, 2024.
4. The Atlantic. The Coming Labor Shortage Is Not Good News. Published July 2, 2024. Accessed August 7, 2024.
5. Federal Reserve Bank of Minneapolis. Who’s not working? Understanding the U.S.’s aging workforce. Published February 27, 2023. Accessed August 29, 2024.
6. Business Insider. Average 401(k) Balance by Age in 2024: Benchmarking Your Retirement Savings. Published August 6, 2024. Accessed August 9, 2024.
7. Mutual of Omaha. Calculator: How long will my money last? Assume: $88,844 savings; annual return of 10%; $1,000/month withdrawal increased by 3.5% per year; federal tax rate 22%. Accessed August 9, 2024.
8. Pew Research Center. The growth of the older workforce. Published December 14, 2023. Accessed July 29, 2024.
9. Pew Research Center. The growth of the older workforce. Published December 14, 2023. Accessed July 29, 2024.
10. Forbes. What Will Happen To The Labor Market When Boomers Retire—Or Yet, Don’t Leave The Workforce? Published February 26, 2024. Accessed September 4, 2024.
11. AIHR. Aging Workforce Challenges: Trends, Statistics and Impact. Accessed August 29, 2024.
12. Transamerica Center for Retirement Studies®. Life in Retirement: Pre-Retiree Expectations and Retiree Realities. Published September 2023. Accessed September 4, 2024.
13. National Bureau of Economic Research (NBER). How are Employers Reacting to an Aging Workforce? Published January 2020. Accessed August 5, 2024.
14. Journal of Intelligence. Critical Thinking: Creating Job-Proof Skills for the Future of Work. Published online October 9, 2023. Accessed August 1, 2024.
15. Bain & Company. Better with Age: The Rising Importance of Older Workers. Published 2023. Accessed August 1, 2024.
16. Johns Hopkins Medicine. Polypharmacy in Adults 60 and Older. Accessed August 8, 2024.
17. GoodRx. Statins. ACE Inhibitors. Accessed August 8, 2024.
18. Johns Hopkins Medicine. Polypharmacy in Adults 60 and Older. Accessed August 8, 2024.
19. ibid.
20. BMJ Open Quality. Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings. Published July 6, 2021. Accessed August 30, 2024.
21. NPJ Aging. Healthcare on the brink: navigating the challenges of an aging society in the United States. Published April 6, 2024. Accessed August 28, 2024.
22. American Journal of Cardiology. Healthcare Expenditure Associated with Polypharmacy in Older Adults with Cardiovascular Diseases. Published April 15, 2022. Accessed August 8, 2024.
23. Scientific American. Why Aging Comes in Dramatic Waves in Our 40s and 60s. Published August 27, 2024. Accessed August 29, 2024.
24. Transamerica Center for Retirement Studies®. Life in Retirement: Pre-Retiree Expectations and Retiree Realities. Published September 2023. Accessed September 4, 2024.
25. Ohio Capital Journal. Report: “Specialty” drugs are by far the most expensive, but classification seems arbitrary. Published May 15, 2023. Accessed September 4, 2024.